Endurant Capital Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-5,646
| Closed | -$687K | – | 24 |
|
|
2023
Q4 | $687K | Sell |
5,646
-11,833
| -68% | -$1.32M | 3.94% | 10 |
|
|
2023
Q3 | $1.96M | Buy |
+17,479
| New | +$2.22M | 1.76% | 20 |
|
|
2023
Q2 | – | Sell |
-9,283
| Closed | -$1.2M | – | 61 |
|
|
2023
Q1 | $1.2M | Buy |
+9,283
| New | +$1.17M | 0.62% | 38 |
|
|
2022
Q3 | – | Sell |
-9,949
| Closed | -$1.04M | – | 68 |
|
|
2022
Q2 | $1.04M | Buy |
+9,949
| New | +$1.18M | 0.37% | 41 |
|
|
2020
Q4 | – | Sell |
-55,861
| Closed | -$7.38M | – | 73 |
|
|
2020
Q3 | $7.38M | Buy |
55,861
+8,442
| +18% | +$1.1M | 2.18% | 13 |
|
|
2020
Q2 | $5.5M | Sell |
47,419
-49,500
| -51% | -$5.7M | 0.3% | 18 |
|
|
2020
Q1 | $9.51M | Sell |
96,919
-43,330
| -31% | -$5.68M | 4.31% | 8 |
|
|
2019
Q4 | $20.4M | Sell |
140,249
-16,822
| -11% | -$2.32M | 6.42% | 3 |
|
|
2019
Q3 | $20.9M | Buy |
157,071
+44,150
| +39% | +$5.7M | 7.51% | 2 |
|
|
2019
Q2 | $12.9M | Buy |
112,921
+33,316
| +42% | +$3.9M | 5.09% | 3 |
|
|
2019
Q1 | $9.87M | Sell |
79,605
-48,017
| -38% | -$5.46M | 3.9% | 8 |
|
|
2018
Q4 | $12.9M | Buy |
127,622
+86,871
| +213% | +$9.77M | 6.79% | 3 |
|
|
2018
Q3 | $5.2M | Buy |
40,751
+17,620
| +76% | +$2.1M | 2.31% | 13 |
|
|
2018
Q2 | $2.5M | Buy |
+23,131
| New | +$2.52M | 1.09% | 25 |
|
|
2017
Q4 | – | Sell |
-10,197
| Closed | -$1.16M | – | 93 |
|
|
2017
Q3 | $1.16M | Buy |
+10,197
| New | +$1.18M | 0.35% | 63 |
|
|
2017
Q2 | – | Sell |
-6,040
| Closed | -$716K | – | 102 |
|
|
2017
Q1 | $716K | Sell |
6,040
-15,965
| -73% | -$1.81M | 0.23% | 74 |
|
|
2016
Q4 | $2.21M | Sell |
22,005
-11,175
| -34% | -$1.2M | 0.91% | 40 |
|
|
2016
Q3 | $4.19M | Buy |
33,180
+1,039
| +3% | +$128K | 1.55% | 23 |
|
|
2016
Q2 | $3.76M | Sell |
32,141
-63,345
| -66% | -$7.17M | 1.26% | 28 |
|
|
2016
Q1 | $9.88M | Sell |
95,486
-40,891
| -30% | -$3.96M | 3.2% | 7 |
|
|
2015
Q4 | $13.6M | Buy |
136,377
+101,666
| +293% | +$9.95M | 4.54% | 3 |
|
|
2015
Q3 | $3.17M | Buy |
34,711
+9,064
| +35% | +$909K | 1.06% | 36 |
|
|
2015
Q2 | $2.72M | Buy |
+25,647
| New | +$2.84M | 0.8% | 36 |
|
|
2015
Q1 | – | Sell |
-9,991
| Closed | -$1.1M | – | 105 |
|
|
2014
Q4 | $1.1M | Buy |
+9,991
| New | +$1.05M | 0.43% | 63 |
|
Other funds holding ZBH
Endurant Capital Management's ZBH Position: Q1 2024 in Review
Endurant Capital Management sold out of Zimmer Biomet (ZBH) in Q1 2024, closing a stake of 5,646 shares — an estimated $687K sold.
Endurant Capital Management first reported a position in ZBH in Q4 2014 and held it in 24 quarters. The position peaked at $20.9M in Q3 2019. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.
- Endurant Capital Management reported no remaining Zimmer Biomet position as of Q1 2024 after selling out during the quarter.
- Endurant Capital Management sold 5,646 Zimmer Biomet shares in Q1 2024, an estimated $687K.
- Endurant Capital Management first reported a position in Zimmer Biomet in Q4 2014 and held it in 24 quarters.
- Endurant Capital Management's Zimmer Biomet position peaked at $20.9M in Q3 2019.
- 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.
Based on Endurant Capital Management's 13F filing for Q1 2024.